Beta Bionics to Present at the Bank of America Securities Health Care Conference
Beta Bionics, Inc. will present at the Bank of America Securities Health Care Conference in Las Vegas on May 12, 2026. The company specializes in advanced diabetes management solutions and their product, the iLet Bionic Pancreas, is the first FDA-cleared insulin delivery device that autonomously determines insulin doses.
IRVINE, Calif., April 27, 2026 (GLOBE NEWSWIRE) — Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today announced that management will present at the Bank of America Securities Health Care Conference in Las Vegas on Tuesday, May 12, 2026 at 2:20 pm Eastern Time (11:20 am Pacific Time).